CD274 and breast cancer: This study also investigated whether hesperidin prevents metastasis phenotypes by reducing PD-L1 expression of the MDA-MB231 cells and found that hesperidin acts as an inhibitor of the immune checkpoint, PD-L1, in breast cancer development.